Learn More
Medchemexpress LLC Pamufetinib mesylate | 1688673-09-7 | 99.2% | 614.66 g/mol | C28H27FN4O7S2 | 50MG

Supplier: Medchemexpress LLC HY12423A50MG
Pamufetinib mesylate is a research-grade small-molecule multi-kinase inhibitor that targets vascular endothelial growth factor receptor (VEGFR) and hepatocyte growth factor receptor (c-Met/HGFR). It exhibits potent activity in biochemical assays, with reported IC50 values near 30 nM for VEGFR2 and 32 nM for MET, and is intended for in vitro and preclinical research use only.
- High purity suitable for research (reported 99.17%).
- Potent VEGFR and c-Met inhibition (IC50 ~30-32 nM).
- Available as solid and DMSO solution formats for assay flexibility.
- Characterized molecular weight and formula for analytical work.
- Supplied in multiple pack sizes to support diverse study scales.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.